Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Caribou Biosciences (CRBU) Asset Utilization Ratio (2021 - 2025)

Caribou Biosciences has reported Asset Utilization Ratio over the past 5 years, most recently at 0.06 for Q4 2025.

  • Quarterly Asset Utilization Ratio rose 98.27% to 0.06 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.06 through Dec 2025, up 98.27% year-over-year, with the annual reading at 0.05 for FY2025, 70.34% up from the prior year.
  • Asset Utilization Ratio was 0.06 for Q4 2025 at Caribou Biosciences, up from 0.04 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 0.09 in Q3 2023 and troughed at 0.02 in Q4 2021.
  • The 5-year median for Asset Utilization Ratio is 0.04 (2025), against an average of 0.05.
  • Year-over-year, Asset Utilization Ratio surged 176.53% in 2023 and then plummeted 62.69% in 2024.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.02 in 2021, then surged by 68.92% to 0.04 in 2022, then skyrocketed by 116.14% to 0.08 in 2023, then tumbled by 60.78% to 0.03 in 2024, then soared by 98.27% to 0.06 in 2025.
  • Per Business Quant, the three most recent readings for CRBU's Asset Utilization Ratio are 0.06 (Q4 2025), 0.04 (Q3 2025), and 0.04 (Q2 2025).